ONCE AGAIN LIKE FDC TRADE
BTST JUBILANT CMP @830-820
TGT 860✅--880✅/920🔂/960+++
*2nd tgt hit 880++++ high 883 new lifetime high possible* #JUBILANT
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Find answers to all your questions on live JUBILANT message board: Is JUBILANT buy or sell? Should I buy JUBILANT shares? Why are JUBILANT shares falling? Should I invest in JUBILANT stock?
forum
JUBILANT Share Price Discussion
Jubilant Life Sciences Ltd.
NSE: JUBILANT | BSE: 530019 | ISIN: INE700A01033 | Sector: Pharmaceuticals and health care
N
Reputation: 4,817 • Jun 1 8:58 AM
Buy Jubilant Life Sciences; target of Rs 515: Motilal Oswal
Motilal Oswal is bullish on Jubilant Life Sciences has recommended buy rating on the stock with a target price of Rs 515 in its research report dated May 30, 2020.
Motilal Oswal is bullish on Jubilant Life Sciences has recommended buy rating on the stock with a target price of Rs 515 in its research report dated May 30, 2020.
Moneycontrol
Like
Reply
NSE:JUBILANT price when posted: 464.25
Recent posts in JUBILANT
B
Reputation: 16,592 • Today 4:30 AM
Bullion_King in JUBILANTTrade entered: Buy JUBILANT @832.2 Target@900 S...
Like
Reply
N
Reputation: 4,817 • Aug 8 1:28 AM
Jubilant Life Sciences presents 1,000 vials of Remdesivir to Uttar Pradesh CM Yogi Adityanath
The drug is being made available to over 1,000 hospitals providing COVID-19 treatment in India through the company's distribution network, Jubilant Life Sciences said in a statement.
The drug is being made available to over 1,000 hospitals providing COVID-19 treatment in India through the company's distribution network, Jubilant Life Sciences said in a statement.
Moneycontrol
Like
Reply
N
Reputation: 4,817 • Aug 4 1:58 AM
Jubilant Life Sciences launches generic version of remdesivir for COVID-19 treatment
In order to increase accessibility of the drug to patients below the poverty line and to front-line paramedical staff, Jubilant Bhartia Foundation, a not-for-profit organisation of the Jubilant Group, is launching programs in India aimed at its distribution, it added.
In order to increase accessibility of the drug to patients below the poverty line and to front-line paramedical staff, Jubilant Bhartia Foundation, a not-for-profit organisation of the Jubilant Group, is launching programs in India aimed at its distribution, it added.
Moneycontrol
Like
Reply
N
Reputation: 4,817 • Jul 31 1:53 AM
Remdesivir shortage to ease in August as existing suppliers boost capacity, new manufacturers enter
Around 8 lakh doses are expected to be available in the country in August as new manufacturers are getting ready to enter the market with their generic versions.
Around 8 lakh doses are expected to be available in the country in August as new manufacturers are getting ready to enter the market with their generic versions.
Moneycontrol
Like
Reply